A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer-Reference-Cited by-同舟云学术

A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer

Published:2013-07 Issue:10 Volume:49 Page:2345-2355
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bahassi El Mustapha,Li Ya-Qin,Wise-Draper Trisha M.,Deng Li,Wang Jiang,Darnell Colleen N.,Wilson Keith M.,Wells Susanne I.,Stambrook Peter J.,Rixe Olivier

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference31 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are earlymarkers of carcinogenesis in head and neck cancer;Grandis;Cancer Res,1993

3. Levels of TGF-a and EGFR protein in head and neck squamous cell carcinoma and patient survival;Grandis;J Natl Cancer Inst,1998

4. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma;Ang;Cancer Res,2002

5. Cell signaling by receptor tyrosine kinases;Schlessinger;Cell,2000

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PI3K pathway mutation predicts an activated immune microenvironment and better immunotherapeutic efficacy in head and neck squamous cell carcinoma;World Journal of Surgical Oncology;2023-03-02

2. Prognostic Implications of EGFR, p53, p16, Cyclin D1, and Bcl‐2 in Head and Neck Squamous Cell Carcinoma (HNSCC);Precision Medicine in Oncology;2020-08-14

3. Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review;In Vivo;2017-01-05

4. Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma;Oncotarget;2016-08-19

5. Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology;Molecular Radio-Oncology;2016